NAVIGATION
-
Services
- Lipidomics Services
- Analytical Services
- Nano-Lipid Carrier Services
- Custom Services
- AI-Driven Lipid Research Solutions
- Order
QUICK INQUIRY
AI-Assisted Lipid Design & Selection
InquiryStop Screening. Start Designing the Right Lipid—From Day One.
Finding the "right" lipid is rarely the problem—finding it fast, with confidence, and without costly iteration is. In many projects, weeks or months are lost screening candidates that were never structurally aligned with the end goal. Performance gaps, instability, or late-stage IP conflicts often emerge only after significant investment.
This platform is built to change that dynamic.
Instead of asking "Which lipid should we test?", we start with a more decisive question:
"What should the lipid be?"
Why This Matters Immediately
If you are working on lipid-based systems, you are likely facing one or more of these challenges:
- Too many candidates, too little certainty
Large lipid libraries don't guarantee the right fit—only more variables to test.
- Slow iteration cycles
Synthesis → formulation → testing loops delay timelines and increase cost.
- Unpredictable performance
Small structural differences lead to large functional changes.
- Late-stage IP or feasibility issues
Promising candidates may be difficult to manufacture or commercially restricted.
This platform addresses these issues at the design stage, before resources are committed.
What You Get Instead
A shift from empirical screening to target-driven molecular engineering:
- Start from your requirements
Define the properties that matter—delivery efficiency, stability, pKa, compatibility, or regulatory constraints.
- Get structures that match your goals
AI models translate those requirements into optimized lipid candidates—either by refining known structures or creating entirely new ones.
- Know what to prioritize—before synthesis
Candidates are ranked based on predicted performance, feasibility, and application relevance.
- Reduce downstream risk
Structural similarity and patent analysis are integrated early, helping you avoid dead ends.
How the Platform Works for You
Rather than a single tool, this is a coordinated design system that supports different decision paths:
- Property-Driven Design
Define target physicochemical parameters and receive optimized lipid structures aligned with those specifications.
- De Novo Lipid Creation
Generate entirely new lipid molecules tailored to demanding applications such as nucleic acid delivery, where existing materials fall short.
- Application-Based Selection
Quickly identify the most suitable lipids for your specific use case—whether pharmaceutical, cosmetic, or nutraceutical—without exhaustive screening.
- IP & Feasibility Intelligence
Evaluate novelty, assess patent landscapes, and identify design-around opportunities before committing to development.
What Changes in Your Workflow
Before:
Screen → Test → Fail → Iterate → Re-test
Now:
Define → Predict → Prioritize → Validate
This shift reduces unnecessary experiments and focuses effort on high-probability candidates.
Where This Delivers the Most Value
- Nucleic acid delivery (LNP systems): Optimize ionizable lipids for encapsulation, endosomal escape, and targeting.
- Advanced drug delivery: Improve stability, bioavailability, and formulation performance.
- Cosmetic and topical systems: Balance skin compatibility, sensory properties, and oxidative stability.
- Functional and nutraceutical formulations: Enhance delivery efficiency and regulatory alignment.
Make Design a Competitive Advantage
Lipid performance is no longer limited by what exists—it is defined by what can be designed.
This AI-assisted platform enables a shift from uncertain exploration to intentional, data-driven molecular decisions—reducing time, lowering risk, and improving outcomes across the entire development pipeline.
